We are live on
!
Find out more
PTC
Private Trust Company Portfolio holdings
AUM
$1.25B
Turnover
12.39%
1-Year Est. Return
29.12%
This Fund
S&P 500
This Quarter
Est. Return
-0.34%
1 Year Est. Return
+29.12%
3 Year Est. Return
+79.64%
5 Year Est. Return
+96.77%
10 Year Est. Return
+318.79%
AUM
$295M
AUM Growth
-$12.6M
(-4.1%)
Cap. Flow
-$9.79M
Cap. Flow
% of AUM
-3.32%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,153
New
144
Increased
431
Reduced
499
Closed
148
Avg Time Held
1
year
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.65M |
| 2 |
iShares MSCI United Kingdom ETF
EWU
|
+$1.53M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$973K |
| 4 |
Blackstone
BX
|
+$660K |
| 5 |
American Tower
AMT
|
+$493K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.09M |
| 2 |
iShares S&P Mid-Cap 400 Growth ETF
IJK
|
+$1.38M |
| 3 |
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
|
+$1.23M |
| 4 |
Vodafone
VOD
|
+$1.2M |
| 5 |
Kinder Morgan
KMI
|
+$529K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.53% |
| 2 | Energy | 11.66% |
| 3 | Industrials | 11.07% |
| 4 | Healthcare | 10.76% |
| 5 | Consumer Staples | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
ExxonMobil
XOM
$718B
| $6.04M | 2.05% |
64,221
-31,041
| -33% | -$3.09M |
2013 Q2
5 quarters
|
|
2
Johnson & Johnson
JNJ
$610B
| $4.93M | 1.67% |
46,282
-858
| -2% | -$89K |
2013 Q2
5 quarters
|
|
3
Altria Group
MO
$123B
| $4.74M | 1.61% |
103,270
+1,664
| +2% | +$71.3K |
2013 Q2
5 quarters
|
|
4
GE Aerospace
GE
$324B
| $4.62M | 1.57% |
37,636
-2,514
| -6% | -$313K |
2013 Q2
5 quarters
|
|
5
Northrop Grumman
NOC
$71B
| $4.6M | 1.56% |
34,914
-1,356
| -4% | -$171K |
2013 Q2
5 quarters
|
|
6
Apple
AAPL
$4.99T
| $4.58M | 1.55% |
181,784
-15,352
| -8% | -$377K |
2013 Q2
5 quarters
|
|
7
Procter & Gamble
PG
$365B
| $4.47M | 1.52% |
53,426
-607
| -1% | -$49.7K |
2013 Q2
5 quarters
|
|
8
Chevron
CVX
$430B
| $4.3M | 1.46% |
36,037
-935
| -3% | -$119K |
2013 Q2
5 quarters
|
|
9
Microsoft
MSFT
$4.01T
| $4.23M | 1.44% |
91,233
-4,747
| -5% | -$212K |
2013 Q2
5 quarters
|
|
|
10
AbbVie
ABBV
$501B
| $3.49M | 1.18% |
60,372
+29,706
| +97% | +$1.65M |
2013 Q2
5 quarters
|
|
11
Wells Fargo
WFC
$248B
| $3.43M | 1.16% |
66,120
-4,166
| -6% | -$214K |
2013 Q2
5 quarters
|
|
12
Colgate-Palmolive
CL
$73.9B
| $3M | 1.02% |
45,917
-502
| -1% | -$33.1K |
2013 Q2
5 quarters
|
|
|
13
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $2.75M | 0.94% |
13,979
+4,924
| +54% | +$973K |
2013 Q2
5 quarters
|
|
|
KMP
14
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
| $2.66M | 0.9% |
28,485
-13,780
| -33% | -$1.23M |
2013 Q2
5 quarters
|
|
|
TUZ
15
DELISTED
PIMCO 1-3 Year U.S. Treasury Index Exchange-Traded Fund
TUZ
| $2.59M | 0.88% |
50,805
| – | – |
2013 Q4
3 quarters
|
|
16
Pfizer
PFE
$168B
| $2.48M | 0.84% |
88,356
-7,731
| -8% | -$217K |
2013 Q2
5 quarters
|
|
17
3M
MMM
$85.3B
| $2.46M | 0.84% |
20,785
-949
| -4% | -$114K |
2013 Q2
5 quarters
|
|
18
IBM
IBM
$221B
| $2.33M | 0.79% |
12,862
-1,063
| -8% | -$194K |
2013 Q2
5 quarters
|
|
19
Philip Morris
PM
$312B
| $2.26M | 0.77% |
27,073
-423
| -2% | -$35.8K |
2013 Q2
5 quarters
|
|
20
Bristol-Myers Squibb
BMY
$124B
| $2.2M | 0.75% |
43,023
-1,149
| -3% | -$57.4K |
2013 Q2
5 quarters
|
|
21
Coca-Cola
KO
$396B
| $2.18M | 0.74% |
51,060
-1,697
| -3% | -$70.2K |
2013 Q2
5 quarters
|
|
22
iShares Core S&P Small-Cap ETF
IJR
$103B
| $2.17M | 0.74% |
41,690
-8,930
| -18% | -$486K |
2013 Q2
5 quarters
|
|
23
Honeywell
HON
$66.7B
| $2.17M | 0.74% |
25,912
-263
| -1% | -$22.4K |
2013 Q2
5 quarters
|
|
24
JPMorgan Chase
JPM
$891B
| $2.16M | 0.73% |
35,806
-4,037
| -10% | -$236K |
2013 Q2
5 quarters
|
|
25
Unilever
UL
$139B
| $2.16M | 0.73% |
45,741
+34
| +0.1% | +$1.68K |
2013 Q2
5 quarters
|
|
Similar funds
HFM
PCM
FCCPG
SL
AC
SAM
RWM
JEST
Private Trust Company's Q3 2014 Portfolio in Review
As of Q3 2014, Private Trust Company held 2,153 positions worth $295M, down 4.1% from $307M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Private Trust Company withdrew a net $9.79M in Q3 2014, closing 148 positions and reducing 499 holdings. Its most notable exit was iShares S&P Mid-Cap 400 Growth ETF, an estimated $1.38M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 23% a quarter earlier, followed by Energy and Industrials.
Against the trend, Private Trust Company opened a new position in iShares MSCI United Kingdom ETF worth $1.45M.
- Private Trust Company's largest Q3 2014 buy was iShares MSCI United Kingdom ETF: 37,408 shares worth $1.45M.
- Private Trust Company added most to AbbVie in Q3 2014, an estimated $1.65M increase.
- Private Trust Company's biggest Q3 2014 reduction was ExxonMobil, cutting an estimated $3.09M.
- Private Trust Company fully exited iShares S&P Mid-Cap 400 Growth ETF in Q3 2014, selling an estimated $1.38M.
- Private Trust Company's ten largest holdings make up 16% of its $295M portfolio in Q3 2014.
- Private Trust Company opened 144 new positions and closed 148 in Q3 2014.
- Private Trust Company's portfolio value fell 4.1% quarter-over-quarter to $295M.
Based on Private Trust Company's 13F filing for Q3 2014, filed 9 Oct 2014.